innovative treatments
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
innovative treatments
May 29, 2024, 10:03 |
Opinion
Alfonso Aguarón, Policy Officer for Lung Cancer Europe participated in the Week of Clinical Trials organised by EUPATI España
Lung Cancer Europe shared on LinkedIn: “Last week, Alfonso Aguarón, Policy Officer for Lung Cancer Europe…
May 28, 2024, 07:05 |
Blog
Shahrin Ahmed: The donor pool for high-risk blood cancer patients could be increased through a new stem cell transplant
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: “The donor…
May 15, 2024, 10:13 |
Blog
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 - Senti Biosciences
Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences…
May 10, 2024, 14:28 |
Blog
Amil Družić : Clinic of Oncology at the Clinical center University of Sarajevo became part of the IWWD
Amil Družić, Oncology and Radiotherapy Resident at the Clinical Center University of Sarajevo, posted on LinkedIn:…
Nov 18, 2023, 16:47 |
Opinion
Rafael Fonseca: If you want to make biggest difference in medicine, I suggest you become a clinical investigator
Rafael Fonseca, Chief Innovation Officer at Mayo Clinic in Arizona, posted on X/Twitter. "FELLOWS: While…
Sep 16, 2023, 17:33 |
Blog
Anas Younes: This Blood Cancer Awareness Month, it’s important to highlight the critical need for innovative treatment options for people living with hematological malignancies.
Jul 31, 2023, 17:58 |
Blog
Can only movies come in sequels? Academic Papers can too! - Vivek Subbiah
Can only movies come in sequels? Academic Papers can too! Excited to introduce the…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube